
Realyze Intelligence: AI-driven clinical data analysis for precise patient care in chronic diseases and cancer.
Realyze Intelligence was founded with the mission to revolutionize clinical data analysis through advanced AI and machine learning technologies. The company's vision is to enhance patient care by providing clinicians with precise and actionable insights. Realyze's core product leverages natural language processing to transform narrative clinical data into comprehensive patient case studies, aiding in the identification of specific patient populations suffering from chronic diseases and cancer. Their market focus includes healthcare providers and clinical researchers looking to accelerate clinical trial screening and build diverse patient cohorts.
Notable figures affiliated with Realyze Intelligence include experts in AI, machine learning, and healthcare data analytics. The company has attracted significant attention from investors interested in the intersection of technology and healthcare. Key achievements include the successful deployment of their software in multiple healthcare settings, leading to faster patient enrollment in clinical trials and improved real-world data insights. Overall, Realyze Intelligence has made a substantial impact on the efficiency and precision of clinical data analysis, ultimately contributing to better patient outcomes.
Companies similar to Realyze Intelligence include Readout AI, Deep 6 AI, Intelligencia and Medical Search Technologies.
Realyze Intelligence was founded in 2020.
Realyze Intelligence's headquarters is located in Pittsburgh, PA, US.
Realyze Intelligence's most recent funding round was for $1.3M (USD) in July 2023.
As of Jul 11, 2023, Realyze Intelligence has raised a total of $1.3M (USD).
Realyze Intelligence has 30 employees as of Feb 5, 2024.
Intelligencia
intelligencia.ai